 Connection
Elaine Urbina to Hyperlipoproteinemia Type II
This is a "connection" page, showing publications Elaine Urbina has written about Hyperlipoproteinemia Type II.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.406 |
|
|
|
-
Zhang Y, Woo JG, Urbina EM, Jacobs DR, Moran AE, de Ferranti SD. Low-Density Lipoprotein Cholesterol Trajectories and Prevalence of High Low-Density Lipoprotein Cholesterol Consistent With Heterozygous Familial Hypercholesterolemia in US Children. JAMA Pediatr. 2021 10 01; 175(10):1071-1074.
Score: 0.182
-
Urbina EM, de Ferranti SD. Lipid Screening in Children and Adolescents. JAMA. 2016 Aug 09; 316(6):589-91.
Score: 0.128
-
Stein EA, Marais AD, Szamosi T, Raal FJ, Schurr D, Urbina EM, Hopkins PN, Karki S, Xu J, Misir S, Melino M. Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia. J Pediatr. 2010 Feb; 156(2):231-6.e1-3.
Score: 0.080
-
McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, Hayman LL, Daniels SR. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007 Apr 10; 115(14):1948-67.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|